Weak D types in the Egyptian population

American Journal of Clinical Pathology

Volumn 139, Issue 6, 2013, Pages 806-811

  Hussein, Eiman ^a   Teruya, Jun ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Anti D alloimmunization; Egyptian population; Weak D alleles

Indexed keywords

RHESUS D ANTIGEN;

ALLOIMMUNIZATION; ARTICLE; CHILD; CHILDHOOD DISEASE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SCREENING TEST; SEROTYPING; THALASSEMIA;

ANTI-D ALLOIMMUNIZATION; EGYPTIAN POPULATION; WEAK D ALLELES;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GROUPING AND CROSSMATCHING; EGYPT; GENOTYPE; HUMANS; ISOANTIBODIES; POLYMERASE CHAIN REACTION; RH-HR BLOOD-GROUP SYSTEM;

EID: 84878414541     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP1T9FGZBHIQET     Document Type: Article

References (48)

1. Wagner FF, Kasulke D, Kerowgan M, et al. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. Infusionsther Transfusionsmed. 1995;22:285-290.
2. Wagner FF, Eicher NI, Jørgensen JR, et al. DNB: a partial D with anti-D frequent in Central Europe. Blood. 2002;15:2253-2256. (Pubitemid 35001265)
3. Ansart-Pirenne H, Asso-Bonnet M, Le Pennec PY, et al. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion. 2004;44:1282-1286. (Pubitemid 39129238)
4. Denomme GA, Wagner FF, Fernandes BJ, et al. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion. 2005;45:1554-1560.
5. Shao CP, Maas JH, Su YQ, et al. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang. 2002;83:156-161.
6. Legler TJ, Wiemann V, Ohto H, et al. D (Va) category phenotype and genotype in Japanese families. Vox Sang. 2000;78:194-197. (Pubitemid 30248959)
7. Colin Y, Cherif-Zahar B, Le Van Kim C, et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood. 1991;78:2747-2752.
8. Westhoff CM. The structure and function of the Rh antigen complex. Semin Hematol. 2007;44:42-50. (Pubitemid 46013923)
9. Flegel WA, Wagner FF. Molecular biology of partial D and weak D: implications for blood bank practice. Clin Lab. 2002;48:53-59. (Pubitemid 34110584)
10. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood. 2000;95:2699-2708. (Pubitemid 30210552)
11. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol. 2006;13:476-483. (Pubitemid 44607451)
12. Sun CF, Chou CS, Lai NC, et al. RHD gene polymorphisms among RhD-negative Chinese in Taiwan. Vox Sang. 1998;75:52-57.
13. Okuda H, Kawano M, Iwamoto S, et al. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest. 1997;15:373-379. (Pubitemid 27349084)
14. Lee YL, Chiou HL, Hu SN, et al. Analysis of RHD genes in Taiwanese RhD-negative donors by the multiplex PCR method. J Clin Lab Anal. 2003;17:80-84.
15. Li Q, Hou L, Guo ZH, et al. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang. 2009;97:139-146.
16. Wagner FF, Gassner C, Müller TH, et al. Molecular basis of weak D phenotypes. Blood. 1999;93:385-393. (Pubitemid 29019427)
17. Avent ND, Reid ME. The Rh blood group system: a review. Blood. 2000;15:375-387. (Pubitemid 30041644)
18. Cruz BR, Chiba AK, Moritz E, et al. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med. 2012;22:84-89.
19. Krog GR, Clausen FB, Berkowicz A, et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion. 2011;51:2278-2285.
20. Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion. 2005;45:520-526.
21. Flegel WA. Blood group genotyping in Germany. Transfusion. 2007;47:47S-53S. (Pubitemid 46934294)
22. Flegel WA. Homing in on D antigen immunogenicity. Transfusion. 2005;45:466-468.
23. Gassner C, Doescher A, Drnovsek TD, et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion. 2005;45:527-538.
24. Mollinson PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 10th ed. Oxford, England: Blackwell Science; 1993.
25. Roback JD, ed. Technical Manual. 17th ed. Bethesda, MD: American Association of Blood Banks; 2011.
26. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor- recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39:225-235.
27. Olerup O, Zetterquist H. DR "low-resolution" PCR-SSP typing: a correlation and an update. Tissue Antigens. 1993;1:55-56.
28. Williams M. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review. Br J Biomed Sci. 2000;57:142-149. (Pubitemid 30417065)
29. Westhoff CM. Rh complexities: serology and DNA genotyping. Transfusion. 2007;47:17S-22S. (Pubitemid 46934289)
30. Beck ML, Harding J. Incidence of D category VI among Du donors in the USA. Transfusion. 1991;31(S):25.
31. American Association of Blood Banks. Standards for Blood Banks and Transfusion Services. 28th ed. Bethesda, MD: American Association of Blood Banks; 2012.
32. Reid ME. Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion. 2003;43:1748-1757. (Pubitemid 37518084)
33. Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion. 2005;45:680-688. (Pubitemid 40656378)
34. Pham BN, Roussel M, Peyrard T, et al. Anti-D investigations in individuals expressing weak D type 1 or weak D type 2: allo- or autoantibodies? Transfusion. 2011;51:2679-2685.
35. Tippett P, Lomas-Francis C, Wallace M. The RH antigen D: partial D antigens and associated low incidence antigens. Vox Sang. 1996;70:123-131. (Pubitemid 26128763)
36. Wang D, Lane C, Quillen K. Prevalence of RhD variants, confirmed by molecular genotyping, in a multiethnic prenatal population. Am J Clin Pathol. 2010;134:438-442.
37. Krumpel B. Are weak D RBCs really immunogenic? Transfusion. 2006;46:1061-1066.
38. Schmidt PJ. Are weak D red blood cells really immunogenic? Transfusion. 2006;46:2029-2030. (Pubitemid 44631613)
39. Garratty G. Do we need to be more concerned about weak D antigens? Transfusion. 2005;45:1547-1551.
40. Frohn C, Dumbgen L, Brand JM, et al. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion. 2003;43:893-898. (Pubitemid 36753939)
41. Felgel WA, Khull SR, Wagner FF. Primary anti-D immunization by weak D type 2 RBCs. Transfusion. 2000;40:428-434. (Pubitemid 30230506)
42. Wagner FF, Frohmajer A, Felgel WA. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001;2:10.
43. Smith NA, Ala FA, Lee D, et al. A multi-center trial of monoclonal anti-D in the prevention of Rh- immunization of RhD- male volunteers by RhD+ red cells. Transfus Med. 2000;10:18.
44. Schmidt PJ, Morrison EC, Shohl J. The antigenicity of the Rh0 (Du) blood factor. Blood. 1962;20:196-202.
45. Hussein EA, Elansarry M, Dawood N, et al. Alloimmunization in multitransfused Egyptian patients with β-thalassemia [abstract]. Transfusion. 2007;47:167A-168A.
46. el-Danasoury AS, Eissa DG, Abdo RM, et al. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion. 2012;52:43-47.
47. Sadeghian MH, Keramati MR, Badiei Z, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci. 2009;3:95-98.
48. Polin H, Danzer M, Gaszner W, et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion. 2009;49:676-681.